The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Birdi, Daljit Singh
    Director born in May 1970
    Individual (6 offsprings)
    Officer
    2024-02-23 ~ now
    OF - director → CIF 0
    Mr Daljit Singh Birdi
    Born in May 1970
    Individual (6 offsprings)
    Person with significant control
    2023-05-02 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 2
    Moosa, Iqbal
    Director born in October 1963
    Individual (6 offsprings)
    Officer
    2015-04-15 ~ now
    OF - director → CIF 0
    Mr Iqbal Moosa
    Born in October 1963
    Individual (6 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
parent relation
Company in focus

KENSINGTON PHARMA LTD

Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
Brief company account
Intangible Assets
61,395 GBP2024-04-30
95,683 GBP2023-04-30
Total Inventories
82,701 GBP2024-04-30
35,792 GBP2023-04-30
Debtors
Current
320,177 GBP2024-04-30
279,387 GBP2023-04-30
Cash at bank and in hand
107,019 GBP2024-04-30
212,939 GBP2023-04-30
Current Assets
509,897 GBP2024-04-30
528,118 GBP2023-04-30
Net Current Assets/Liabilities
-486,423 GBP2024-04-30
-740,018 GBP2023-04-30
Net Assets/Liabilities
-425,028 GBP2024-04-30
-644,335 GBP2023-04-30
Average Number of Employees
12023-05-01 ~ 2024-04-30
22022-05-01 ~ 2023-04-30
Intangible Assets - Gross Cost
Development expenditure
211,518 GBP2024-04-30
218,138 GBP2023-04-30
Intangible Assets - Gross Cost
211,518 GBP2024-04-30
218,138 GBP2023-04-30
Intangible assets - Disposals
-6,620 GBP2023-05-01 ~ 2024-04-30
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
150,123 GBP2024-04-30
122,455 GBP2023-04-30
Intangible Assets - Accumulated Amortisation & Impairment
150,123 GBP2024-04-30
122,455 GBP2023-04-30
Intangible Assets - Increase From Amortisation Charge for Year
Development expenditure
27,668 GBP2023-05-01 ~ 2024-04-30
Intangible Assets - Increase From Amortisation Charge for Year
27,668 GBP2023-05-01 ~ 2024-04-30
Intangible Assets
Development expenditure
61,395 GBP2024-04-30
95,683 GBP2023-04-30
Other types of inventories not specified separately
82,701 GBP2024-04-30
35,792 GBP2023-04-30
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
309,926 GBP2024-04-30
242,820 GBP2023-04-30
Debtors
Current, Amounts falling due within one year
320,177 GBP2024-04-30
279,387 GBP2023-04-30

  • KENSINGTON PHARMA LTD
    Info
    Registered number 09543292
    Unit A Newlands House, 60 Chain House Lane, Whitestake Preston, Lancashire PR4 4LG
    Private Limited Company incorporated on 2015-04-15 (10 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.